Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan L Ryan

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Alcoholism, Clinical and Experimental Research|May 18, 2016
Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications DevelopmentRaye Z Litten, Daniel E Falk, Megan L Ryan, et al.
Handbook of Experimental Pharmacology|October 20, 2019
Medication Development for Alcohol Use Disorder: A Focus on Clinical StudiesLorenzo Leggio, Daniel E Falk, Megan L Ryan, et al.
Handbook of Experimental Pharmacology|January 3, 2018
Advances in Pharmacotherapy Development: Human Clinical StudiesRaye Z Litten, Daniel E Falk, Megan L Ryan, et al.
Substance Abuse|March 2, 2016
Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safetyRaye Z Litten, Bonnie B Wilford, Daniel E Falk, et al.
Contemporary Clinical Trials|August 14, 2016
An exploratory evaluation of Take Control: A novel computer-delivered behavioral platform for placebo-controlled pharmacotherapy trials for alcohol use disorderEric G Devine, Megan L Ryan, Daniel E Falk, et al.
Addiction Biology|March 31, 2012
Medications development to treat alcohol dependence: a vision for the next decadeRaye Z Litten, Mark Egli, Markus Heilig, et al.
Alcoholism, Clinical and Experimental Research|May 5, 2020
Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of VareniclineRobert Miranda, Stephanie S O'Malley, Hayley Treloar Padovano, et al.
Alcohol, Clinical & Experimental Research|December 3, 2024
Effects of a novel GABA-B positive allosteric modulator, ASP8062, on alcohol cue-elicited craving and naturalistic alcohol consumption in a multisite randomized, double-blind, placebo-controlled trialJoseph P Schacht, Lara A Ray, Robert Miranda, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 20, 2025
Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trialStephanie S O'Malley, Robert Miranda, Sarah W Book, et al.
Alcoholism, Clinical and Experimental Research|September 29, 2011
A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patientsRaye Z Litten, Joanne B Fertig, Daniel E Falk, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Alcoholism, Clinical and Experimental Research|May 18, 2016
Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications DevelopmentRaye Z Litten, Daniel E Falk, Megan L Ryan, et al.
Handbook of Experimental Pharmacology|October 20, 2019
Medication Development for Alcohol Use Disorder: A Focus on Clinical StudiesLorenzo Leggio, Daniel E Falk, Megan L Ryan, et al.
Handbook of Experimental Pharmacology|January 3, 2018
Advances in Pharmacotherapy Development: Human Clinical StudiesRaye Z Litten, Daniel E Falk, Megan L Ryan, et al.
Substance Abuse|March 2, 2016
Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safetyRaye Z Litten, Bonnie B Wilford, Daniel E Falk, et al.
Contemporary Clinical Trials|August 14, 2016
An exploratory evaluation of Take Control: A novel computer-delivered behavioral platform for placebo-controlled pharmacotherapy trials for alcohol use disorderEric G Devine, Megan L Ryan, Daniel E Falk, et al.
Addiction Biology|March 31, 2012
Medications development to treat alcohol dependence: a vision for the next decadeRaye Z Litten, Mark Egli, Markus Heilig, et al.
Alcoholism, Clinical and Experimental Research|May 5, 2020
Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of VareniclineRobert Miranda, Stephanie S O'Malley, Hayley Treloar Padovano, et al.
Alcohol, Clinical & Experimental Research|December 3, 2024
Effects of a novel GABA-B positive allosteric modulator, ASP8062, on alcohol cue-elicited craving and naturalistic alcohol consumption in a multisite randomized, double-blind, placebo-controlled trialJoseph P Schacht, Lara A Ray, Robert Miranda, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 20, 2025
Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trialStephanie S O'Malley, Robert Miranda, Sarah W Book, et al.
Alcoholism, Clinical and Experimental Research|September 29, 2011
A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patientsRaye Z Litten, Joanne B Fertig, Daniel E Falk, et al.
Pageof 2